本頁面由Tiger Trade Technology Pte. Ltd.提供服務

萬達生物製藥

5.11
+0.11002.20%
盤後5.110.00000.00%16:04 EDT
成交量:64.68萬
成交額:329.88萬
市值:3.09億
市盈率:-1.10
高:5.17
開:4.99
低:4.99
收:5.00
52周最高:9.94
52周最低:4.27
股本:6,046.27萬
流通股本:4,766.05萬
量比:0.88
換手率:1.36%
股息:- -
股息率:- -
每股收益(TTM):-4.6291
每股收益(LYR):-3.7413
淨資產收益率:-77.81%
總資產收益率:-22.38%
市淨率:1.40
市盈率(LYR):-1.37

資料載入中...

2022/02/15

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/04

重要事件披露

8-K - Current report
2022/01/14

重要事件披露

8-K - Current report
2021/12/02

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/09/17

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/09/13

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/08/23

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/08/17

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/07/30

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/07/29

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/07/28

重要事件披露

8-K - Current report
2021/06/10

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/06/10

重要事件披露

8-K - Current report
2021/05/06

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/05

重要事件披露

8-K - Current report
2021/02/25

重要事件披露

8-K - Current report
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals